Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2380)
All Articles published online
|
Aug 7, 2006 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Goyal A, Suneetha P, Kumar G, Shukla DK, Arora N, Sarin SK. CCR5Δ32 mutation does not influence the susceptibility to HCV infection, severity of liver disease and response to therapy in patients with chronic hepatitis C. World J Gastroenterol 2006; 12(29): 4721-4726 [PMID: 16937446 DOI: 10.3748/wjg.v12.i29.4721] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i29/4721.htm |
| Number | Citing Articles |
| 1 |
Julie R. Jonsson, David M. Purdie, Andrew D. Clouston, Elizabeth E. Powell. Recognition of Genetic Factors Influencing the Progression of Hepatitis C. Molecular Diagnosis & Therapy 2008; 12(4): 209 doi: 10.1007/BF03256286
|
| 2 |
Manuel Romero-Gomez, Mohamed Eslam, Agustín Ruiz, Marta Maraver. Genes and hepatitis C: susceptibility, fibrosis progression and response to treatment. Liver International 2011; 31(4): 443 doi: 10.1111/j.1478-3231.2011.02449.x
|
| 3 |
Jacob Nattermann, Jörg Timm, Hans Dieter Nischalke, Anne Olbrich, Monika Michalk, Hans L. Tillmann, Thomas Berg, Heiner Wedemeyer, Hannelore Tenckhoff, Manfred Wiese, Ulrike Kullig, Uwe Göbel, Emanuela Capka, Ingolf Schiefke, Wolfgang Güthof, Kurt Grüngreiff, Ingrid König, Michael Roggendorf, Tilman Sauerbruch, Ulrich Spengler. The predictive value of IL28B gene polymorphism for spontaneous clearance in a single source outbreak cohort is limited in patients carrying the CCR5Δ32 mutation. Journal of Hepatology 2011; 55(6): 1201 doi: 10.1016/j.jhep.2011.03.011
|
| 4 |
Jeremy Wheeler, Mary McHale, Vicky Jackson, Michelle Penny. Assessing Theoretical Risk and Benefit suggested by Genetic Association Studies of CCR5: Experience in a Drug Development Programme for Maraviroc. Antiviral Therapy 2007; 12(2): 233 doi: 10.1177/135965350701200208
|
| 5 |
Shafiq Ur Rehman, Mahd Rauf, Zaigham Abbas, Muhammed Haroon Hamed, Ishtiaq Qadri. Role of Some Predominant Host Immunomodulators' Single Nucleotide Polymorphisms in Severity of Hepatitis B Virus and Hepatitis C Virus Infection. Viral Immunology 2016; 29(10): 536 doi: 10.1089/vim.2016.0062
|
| 6 |
Bertram Bengsch, Robert Thimme, Hubert E. Blum. Role of Host Genetic Factors in the Outcome of Hepatitis C Virus Infection. Viruses 2009; 1(2): 104 doi: 10.3390/v1020104
|
| 7 |
V Suppiah, N J Armstrong, K S O'Connor, T Berg, M Weltman, M L Abate, U Spengler, M Bassendine, G J Dore, W L Irving, E Powell, J Nattermann, T Mueller, S Riordan, G J Stewart, J George, D R Booth, G Ahlenstiel, Monika Michalk, Barbara Malik, Patrick McClure, Sherie Smith, David Sheridan, Elizabeth Snape, Vincenzo Fragomeli, Richard Norris, Dianne How-Chow, Julie R Jonsson, Helen Barrie, Sacha Stelzer-Braid, Shona Fletcher, Tanya Applegate, Jason Grebely, Gail Matthews, Mandvi Bharadwaj, Antonina Smedile. CCR5-Δ32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infection. Genes & Immunity 2013; 14(5): 286 doi: 10.1038/gene.2013.15
|
| 8 |
Chloe L. Thio. Host Genetic Factors and Antiviral Immune Responses to Hepatitis C Virus. Clinics in Liver Disease 2008; 12(3): 713 doi: 10.1016/j.cld.2008.03.002
|
| 9 |
Joel Henrique Ellwanger, Bruna Kulmann-Leal, Valéria de Lima Kaminski, Andressa Gonçalves Rodrigues, Marcelo Alves de Souza Bragatte, José Artur Bogo Chies. Beyond HIV infection: Neglected and varied impacts of CCR5 and CCR5Δ32 on viral diseases. Virus Research 2020; 286: 198040 doi: 10.1016/j.virusres.2020.198040
|
| 10 |
Amal Abdul-rasheed El-Moamly, Mohamed Aly El-Sweify, Rafiaa M. Rashad, Esam M. Abdalla, Mostafa M. Ragheb, Mohamed M. Awad. Role of CCR5Δ32 mutation in protecting patients with Schistosoma mansoni infection against hepatitis C viral infection or progression. Parasitology Research 2013; 112(7): 2745 doi: 10.1007/s00436-013-3380-9
|
| 11 |
Jacob K. Nattermann, Jürgen K. Rockstroh. HIV and Liver Disease. 2012; : 67 doi: 10.1007/978-1-4419-1712-6_8
|
| 12 |
Sharif B. Missiha, Mario Ostrowski, E. Jenny Heathcote. Disease Progression in Chronic Hepatitis C: Modifiable and Nonmodifiable Factors. Gastroenterology 2008; 134(6): 1699 doi: 10.1053/j.gastro.2008.02.069
|
| 13 |
Joel Henrique Ellwanger, Bruna Kulmann Leal, Jacqueline María Valverde-Villegas, Daniel Simon, Camila Guerra Marangon, Vanessa Suñé Mattevi, Rosmeri Kuhmmer Lazzaretti, Eduardo Sprinz, Regina Kuhmmer, José Artur Bogo Chies. CCR5Δ32 in HCV infection, HCV/HIV co-infection, and HCV-related diseases. Infection, Genetics and Evolution 2018; 59: 163 doi: 10.1016/j.meegid.2018.02.002
|